• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • T Regulatory Cell Therapies
      • SOD1 Therapies & Trials
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • Diagnostic Delay (in development)
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Meeting
    • Allied Professionals Forum
    • Alliance Webinars
    • ALS/MND Connect
    • Global Day
    • March of Faces
    • Patient Fellows Program
    • Global CRLI
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Awards

Each year, the International Alliance of ALS/MND Associations honours individuals and teams who make outstanding contributions to the global ALS/MND community. We present four annual awards to recognize excellence in care, research, advocacy, and innovation:

  • Forbes Norris Award
  • Humanitarian Award
  • Allied Health Professional Award
  • Student Innovation Award

Nominations for the 2025 Awards are now open! Click the links below to learn more about each award and submit a nomination.


Forbes Norris Award

Established in 1994, the Forbes Norris Award  honours the legacy of Dr. Forbes “Ted” Norris (1928-1993), a neurologist who dedicated his career to helping people with ALS/MND. This prestigious award recognizes individuals who contribute to the management and advancement of understanding ALS/MND to the benefit of people living with the disease.

Submit a nomination for the 2025 Forbes Norris Award. 

2024 Recipients: Dr. Jonathan D. Glass & Dr. Zachary Simmons

Dr. Jonathan D. Glass has dedicated himself to ALS/MND community for over 30 years. He leads the Emory ALS Center, one of the largest centres in the United States, where he has earned a reputation for providing compassionate, expert care. He has been at the forefront of important research, including the first human trials of stem cell treatment for ALS/MND. He has also built a large collection of patient samples that has helped scientists around the world study ALS/MND, leading to new discoveries about the disease.

“What sets Dr. Glass apart is his passion for bringing science to the clinic,” say Dr. Christina Fournier and Meraida Polak of the Emory ALS Center. “Dr. Glass is an outspoken proponent for the ethical and responsible involvement of ALS/MND patients in research about their disease, and then ensuring that patients reap the rewards of those efforts.”

Dr. Glass’s impact is global. He has collaborated on international projects like Answer ALS and Project MinE, sharing data and insights to help researchers worldwide. He is also a respected mentor, guiding many young doctors and scientists, and strengthening the ALS/MND research community.

Dr. Zachary Simmons has dedicated over four decades to the management of ALS/MND, including his long tenure as the Director of the Penn State Health ALS Center at Penn State Health Milton S. Hershey Medical Center. Through his leadership, he has directly impacted the lives of thousands of ALS/MND patients, providing compassionate care and advancing critical research. His work spans from pioneering telehealth initiatives to developing an ALS/MND-specific quality of life instrument.

Dr. Simmons has also led numerous clinical trials and research projects focused on ALS/MND, cognitive dysfunction and the use of technology in patient care. His contributions to the ALS/MND community have been recognized not only in clinical settings but also through his educational work as Professor of Neurology and Humanities at Penn State College of Medicine and as an active volunteer with The ALS Association in the United States.

“The research and care services he has been associated with demonstrate teamwork, creativity and innovation,” says Tony Heyl from ALS United Mid-Atlantic. “His work enriches the lives of persons living with ALS/MND and their families, giving them help and hope.”

Previous Winners

2023 Dr. Jeremy M. Shefner

2022 Dr. Richard Bedlack

2021 Dr. Adriano Chiò

2020 Professor Ammar Al Chalabi

2018 Dr. Angela Genge

2017 Dr. Merit Cudkowicz

2016 Dr. Mamede de Carvalho

2015 Dr. Terry Heiman-Patterson

2014 Dr. Matthew Kiernan

2013 Dr. Leonard van den Berg

2012 Dr. Benjamin Brooks

2011 Professor Orla Hardiman

2010 Dr. Edward Kasarskis

2009 Professor Christopher Shaw

2008 Dr. Michael Strong

2007 Dame Professor Pamela Shaw

2006 Dr. Walter G. Bradley

2005 Dr. Stanley Appel

2004 Dr. Robert G. Miller

2003 Dr. Robert H. Brown

2002 Professor Vianney DeJong

2001 Dr. Lewis P. (Bud) Rowland

2000 Professor Michael Swash

1999 Dr. Andrew Eisen

1998 Dr. Hiroshi Mitsumoto

1997 Professor Nigel Leigh

1996 Dr. Donald Mulder

1995 Dr. Teepu Siddique

1994 Professor Vincent Meininger


Humanitarian Award

Established in 2000, the Humanitarian Award recognizes non-scientific contributions that have a global impact on the quality of life for people affected by ALS/MND.

Submit a nomination for the 2025 Humanitarian Award. 

2024 Recipient: Evy Reviers (Belgium)

Evy Reviers’s dedication to improving the quality of life in the ALS/MND community comes from her personal experience as the daughter of a person living with ALS/MND. She has worked hard to influence important laws in Belgium that provide of people living with ALS/MND easier access to care, support and resources. These include funding for personal assistance, specialized physiotherapy and dedicated care centres. She also helped establish Middelpunt, a care centre on the Belgian coast, where people living with ALS/MND and their families can enjoy a holiday together, providing much-needed respite.

Evy’s impact goes beyond Belgium. She founded EUpALS, a network of 28 ALS/MND organizations from 22 European countries, to help ensure people living with ALS/MND in Europe have access to clinical trials. She also plays a key role in the TRICALS research initiative, which focuses on finding a cure for ALS/MND, and serves as a patient representative at the European Medicines Agency, helping to shape research and policy decisions.

On a global scale, Evy has led projects to provide equipment like electric wheelchairs to people living with ALS/MND in other countries, directing impacting their quality of life.

Previous Winners

2023 Dr. Lucie Bruijn

2022 Sally Light

2021 Dr. David Taylor

2020 Carol Birks

2019 Dario Ryba

2018 Dr. Brian Dickie

2017 Peter Frates, Patrick Quinn and Anthony Senerchia, Jr., the founders of the Ice Bucket Challenge.

2016 James Allen Heywood and Benjamin Heywood

2015 Jesus Mora

2014 Wendy Abrams

2013 Dr. Jeffrey Dietch

2012 Gudjon Sigurdsson

2011 Danny Reviers and Mia Mahy

2010 Jette Moeller

2009 Professor Kathy Mitchell

2008 Rodney Harris

2007 Tricia Holmes

2006 Mrs. Misao Hashimoto

2005 The MND Association of South Africa

2003 Dr. David Oliver

2002 Dee Holden Norris

2001 Yuko Matsuoka

2000 The MND Association of England, Wales and Northern Ireland


Allied Health Professional Award

Established in 2018, the Allied Health Professional Award recognizes individuals who provide exceptional care to people living with ALS/MND, share their expertise and innovative practices to improve patient care, and contribute to the advancement of ALS/MND clinical management.

Submit a nomination for the 2025 Allied Health Professional Award. 

2024 Recipients: Dr. Alisa Apreleva  and Dr. Tatiana Mesquita e Silva

Alisa Apreleva, PhD, MT-BC, NMT, is a music therapist, researcher and community educator who has spent over 10 years working with ALS/MND patients. She has developed music-based therapies that improve quality of life, focusing on speech, breathing and emotional wellbeing. Alisa also runs Music.ALS, a free online resource filled with practical tools for using music in ALS/MND care.

“I know how difficult it is to find support for complementary programs and treatments for ALS/MND,” says Marina Bialik, CEO of Palliative Care Initiative. “I strongly believe that the decade-long innovative work of Dr. Apreleva in ALS/MND clinical care deserves to be recognized.”

Tatiana Mesquita e Silva, PT, PhD, is a physiotherapist in Brazil who has been a leader in developing new treatments for ALS/MND, particularly in the field of hydrotherapy. She has published educational materials and trained professionals on best practices for care. She is also a long-time advocate for the ALS/MND community, serving as a vice-president of the ALS/MND association in Brazil, and sharing her expertise internationally through her work with the Alliance.

“She has extensive knowledge of physiotherapy for individuals with neurological and neuromuscular diseases, including ALS/MND,” says fellow physiotherapist Sara Feldman, “It is evident she is truly a leader in her area of expertise.”

Previous Winners

2023 Dr. Deirdre Murray

2022 Richard Cave

2021  Dr. Melinda Kavanaugh and Sarah Solomon

2020 John Costello

2019 Rachel Marsden

2018 Dr. Sara Feldman


Student Innovation Award

Established in 2023, the Student Innovation Award aims to raise awareness of ALS/MND within the global student community. It offers students a platform to showcase creative ideas that improve the quality of life for people living with ALS/MND and helps spark innovation in the field.

Submit a nomination for the 2025 Student Innovation Award. 

2024 Recipients: Valeria Otalora Garces, Valentina Gonzalez and Luisa Maria Hormizda Infante

Valeria Otalora Garces, Valentina Gonzalez and Luisa Maria Hormizda Infante, three medical students in Colombia, are being recognized for their work to improve the lives of people living with ALS/MND and other rare diseases.

Over the past three years, these students have developed digital tools that help doctors, caregivers and patients manage rare diseases. They started by creating an app focused on cystic fibrosis, enabling the medical community to exchange experiences and knowledge on this topic.

Valeria, Valentina and Luisa María then turned their attention to ALS/MND, working closely with the ALS/MND association in Colombia to understand the needs of those affected. As a result, they created two key resources: a digital guide for caregivers, doctors and patients with practical information on care, nutrition and managing symptoms; and an app that tracks the progression of ALS/MND. Both are currently being used by the Colombian ALS/MND community.

“It is necessary to give importance to this selfless work and [encourage] more students to become interested in these initiatives,” says research professor Mauricio Plaza Torres. “I am very proud of the work of these students, which uses technology to improve the quality of life of patients affected by diseases such as ALS/MND.”

Valeria, Valentina and Luisa María are continuing their research and are now studying ways for people living with ALS/MND to use brain-computer interface technology to help control devices.

Their work is making a difference in the ALS/MND community, and their achievements serve as an example to others in the student community and beyond.

Previous Winners

2023 Gauri Desai and Zineb Flahy

Primary Sidebar

About

  • Who We Are
  • Board of Trustees
  • Advisory Councils/Committees
    • PALS and CALS Advisory Council
    • Innovation and Technology Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Archives
    • Newsletters
    • Meetings
  • Awards

  • Fabio Correia

    Fabio Correia

  • David Bishop

    David Bishop

  • Liam Dwyer, England

    Liam Dwyer, England

  • Liam Dwyer, England

    Liam Dwyer, England

  • Ana María Zavala, FYADENMAC, Diagnosed 2019, Mexico

    Ana María Zavala, FYADENMAC, Diagnosed 2019, Mexico

  • Orlando Ruiz, Diagnosed 2001,  ACELA, Colombia

    Orlando Ruiz, Diagnosed 2001, ACELA, Colombia

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Norm MacIsaac,  ALS Society of Canada,  ALS Society of Quebec,  Diagnosed 2014

    Norm MacIsaac, ALS Society of Canada, ALS Society of Quebec, Diagnosed 2014

  • Claudette Sturk, ALS Society of Canada

    Claudette Sturk, ALS Society of Canada
    Picture2

  • Wilfried Leusing

    Wilfried Leusing

  • Art Eggert, USA

    Art Eggert, USA

  • Lucy Lintott, Diagnosed 2013 , MND Scotland, UK

    Lucy Lintott, Diagnosed 2013 , MND Scotland, UK

  • Shera Mukherjee, Diagnosed 2013,  Asha Ek Hope Foundation, India

    Shera Mukherjee, Diagnosed 2013, Asha Ek Hope Foundation, India

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Margarita Pizarro, Asociacion ELA Argentina, Diagnosed 2017, Argentina

    Margarita Pizarro, Asociacion ELA Argentina, Diagnosed 2017, Argentina

  • Shay Rishoni

    Shay Rishoni

  • England-Lee-Millard, UK

    England-Lee-Millard, UK

  • Margreth Burger-Saile, Diagnosed 2011,  ALS Schweiz,  Switzerland

    Margreth Burger-Saile, Diagnosed 2011, ALS Schweiz, Switzerland

  • Armando González Gómez, ACELA, Colombia

    Armando González Gómez, ACELA, Colombia

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Enzo Maccarrone, AISLA ONLUS, Italy

    Enzo Maccarrone, AISLA ONLUS, Italy

  • Phil Rossall, MND-Association, UK

    Phil Rossall, MND-Association, UK

  • Mark Miller

    Mark Miller

  • Ana Lilia RodriguezApoyo Integral Gila A.C., Diagnosed 2018, Mexico

    Ana Lilia RodriguezApoyo Integral Gila A.C., Diagnosed 2018, Mexico

  • Purningam Jacob, Diagnosed 2012 , Asha Ek Hope Foundation, India

    Purningam Jacob, Diagnosed 2012 , Asha Ek Hope Foundation, India

  • Jan Zuring, Diagnosed 2010 , The Netherlands

    Jan Zuring, Diagnosed 2010 , The Netherlands

  • Juvenal Bayona Romero

    Juvenal Bayona Romero

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Lombana, Spain

    Lombana, Spain

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Ian Gale, MND Australia

    Ian Gale, MND Australia

  • Michel Perrozzo, ARSLA, Diagnosed 2015, France

    Michel Perrozzo, ARSLA, Diagnosed 2015, France

  • Anthony (Tony) Lynch, MND New South Wales, Diagnosed 2016, Australia

    Anthony (Tony) Lynch, MND New South Wales, Diagnosed 2016, Australia

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • David Watson,  MND Scotland,  Diagnosed 2018

    David Watson, MND Scotland, Diagnosed 2018

  • H. Todd Kelly, Diagnosed 2013 , ALS Hope Foundation, USA

    H. Todd Kelly, Diagnosed 2013 , ALS Hope Foundation, USA

  • Emilienne Verhaegen, ALS Liga Belgium, Diagnosed 2014

    Emilienne Verhaegen, ALS Liga Belgium, Diagnosed 2014

  • Jon Newsome, Les Turner ALS Foundation, USA

    Jon Newsome, Les Turner ALS Foundation, USA

  • Jorge Melo, ABrELA, Brazil

    Jorge Melo, ABrELA, Brazil

  • Jette Odgaard Villemoes, Muskelsvindfonden, Denmark

    Jette Odgaard Villemoes, Muskelsvindfonden, Denmark

  • 393647_2252248542053_984912751_n

    393647_2252248542053_984912751_n

  • Dorette Lüdi, Diagnosed 2014 , ALS Schweiz, Switzerland

    Dorette Lüdi, Diagnosed 2014 , ALS Schweiz, Switzerland

  • Charlie “Hark” Dourney, Diagnosed 2007 , Hark ALS, USA

    Charlie “Hark” Dourney, Diagnosed 2007 , Hark ALS, USA

  • Jean Waters, Diagnosed 2004, MND Association of England, Wales and N Ireland

    Jean Waters, Diagnosed 2004, MND Association of England, Wales and N Ireland

  • JP

    JP

  • Irene McCaughey, Diagnosed 2011,  MND Australia

    Irene McCaughey, Diagnosed 2011, MND Australia

  • Richard Clark, MND New Zealand,  Diagnosed 2011

    Richard Clark, MND New Zealand, Diagnosed 2011

  • Eddy LeFrançois, Diagnosed 1992,  ALS Canada

    Eddy LeFrançois, Diagnosed 1992, ALS Canada

Learn more about the March of Faces

Latest Tweets

  • Just now

Footer

Subscribe to our Bi-Monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2025 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login